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Saccess may increase the time required, patient discomfort, risk of arterial spasm, and
the need for cross-over to other access sites. Ultrasound (US) guidance has been
demonstrated to facilitate vascular access and reduce vascular complications in
multiple sites and locations, but has not been tested in a multicenter fashion in
transradial access.
Methods: We conducted a multicenter randomized controlled trial of 473 patients
undergoing transradial cardiac catheterization. Four centers (6 hospitals) and 16
operators trained in US guidance participated in the study. Patients were randomized
to needle insertion with either palpation (P) or real-time US guidance (237 P, 236 US).
Primary endpoints were the number of forward attempts required for access, ﬁrst pass
success rate, and time to sheath insertion.
Results: The mean number of attempts was reduced with US guidance (1.65  1.2 vs.
3.05  3.4, p< 0.0001) and the ﬁrst pass success rate improved (64.8% vs. 43.9%,
p< 0.0001). The mean time to sheath insertion was reduced (83  78 vs. 113 
124 seconds, p¼0.0016) as was the median time to insertion (60 [IQR 42-91] vs.
75 [50-119], p<0.005). Ten patients in the control group required cross-over
to US guidance after 5 minutes of failed palpation attempts with 9/10 (90%)
having successful sheath insertion with US. The number of difﬁcult access
procedures was decreased with US guidance (6 vs. 44 for > 5 attempts, p <0.001; 6
vs. 15 for > 5min, p¼0.07). There was no signiﬁcant difference in the rate of operator-
reported spasm (4.2% P vs. 5.5% US, p¼0.53), crossover to other access sites (2.5%
P vs. 1.3% US, p¼0.34), mean patient pain scores (range 0-10) following the
procedure (0.82 P vs. 0.89 US, p¼0.29), or bleeding complications (1.7% P vs. 2.1%
US, p¼0.75).
Conclusions: Ultrasound guidance improves the success and efﬁciency of
radial artery cannulation in patients presenting for transradial catheterization.
NCT01605292
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Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And
Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And
No Closure Devices
Koen Keirse1
1Heilig Hart Hospital, Tienen, Belgium
Background: One of the more recent treatment options for femoro-popliteal,
atherosclerotic lesions, is the application of self-expanding nitinol stents. The use
of 4 French systems, can reduce access site related complications. Although there
are clear indications of the beneﬁts of 4F devices for peripheral applications,
scientiﬁc evidence to support this thesis are still lacking today. The 4EVER trial
attempts to investigate the long-term results (up to 24 months) in patients pre-
senting with intermittent claudication or critical limb ischemia by use of 4 French
systems.
Methods: The 4EVER trial is a prospective, non-randomized, multi-center, multi-
national, controlled trial conducted in 5 sites in Belgium and Germany. Between June
2010 and May 2011, 120 patients were enrolled. The primary endpoint was primary
patency at 12 months, deﬁned as freedom from >50% restenosis at 12 months as
indicated by an independently veriﬁed duplex ultrasound peak systolic velocity ratio
(PSVR) <2.5 in the target vessel with no reintervention.
Results: Of the 120 patients enrolled, 82 (68.33%) were men and the mean age was
71 (47-90; 9.70) years. 83.33% had intermittent claudication and 16.67% pre-
sented with critical limb ischemia. For lesion treatment, 70 (58.33%) patients
received an Astron Pulsar stent, 46 (38.33%) were treated with Pulsar-18 stent
placement and 4 (3.33%) received mixed stent use. The mean lesion length was
43.50mm in the Astron Pulsar group, 105.44mm in the Pulsar-18 group and
145.00mm in the mixed stent group. Kaplan Meier estimation reported a 6-month
primary patency rate of 90.0% and a 6-month freedom of target lesion revascu-
larization of 95.4%. Primary patency rates for the Astron Pulsar group, Pulsar-18
group and mixed stent group at 6 months were 92.2%, 85.3% and 100% respec-
tively. For 103 patients, compression time was recorded with a mean compression
time of 8.12 (2.00-15.00) minutes.
Conclusions: With a high primary patency at 6 months and a low compression time,
this ﬁrst analysis indicates the beneﬁts of treatment with 4 French systems. As these
ﬁrst preliminary 6-month data show promising results, full 12-month data will be
presented at TCT 2013.TCT-280
Impact of catheter sheath insertion into radial artery on vascular endothelial
function as assessed by reactive hyperemia peripheral arterial tonometry
Tomoo Nakata1, Satoshi Ikeda1, Seiji Koga1, Takeo Yoshida1, Miyuki Eto1,
Yuji Koide1, Hiroaki Kawano1, Koji Maemura1
1Department of Cardiovascular Medicine, Nagasaki University Graduate School of
Biomedical Sciences, Nagasaki, Japan
Background: The transradial approach has been accepted as an alternative entry
method for coronary angiography and angioplasty. However, this procedure carries
a risk of injury to the endothelium in the radial artery. Flow-mediated dilation (FMD)
has often been used to investigate vascular endothelial function, and some reportsJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrhave examined the impact of catheter sheath insertion on vascular function using this
method. However, the assessment is limited in that the focus is on only one point of
the brachial or radial artery. Reactive hyperemia peripheral arterial tonometry (RH-
PAT) has recently been developed for the assessment of endothelial function in
peripheral arteries, offering higher reproducibility and easier manipulation. The aim of
this study was to examine vascular dysfunction caused by catheter sheath insertion
into a radial artery using RH-PAT and to compare differences in injuries according to
the size of sheath.
Methods: RH-PAT was measured using an Endo-PAT2000 system. Forty-three
patients receiving transradial catheterization with 6-Fr sheaths (n¼17) or 4-Fr/5-Fr
(n¼26) sheaths underwent Endo-PAT2000 before and the day after catheterization.
RH-PAT was assessed in the arm of sheath placement and in the other arm as
a control. Thirteen subjects in the 6-Fr group were reassessed using RH-PAT at 6
months after catheterization.
Results: RH-PAT values decreased from 2.420.67 before catheterization to
2.080.41 the day after catheterization in the 6-Fr group (p<0.05), while the
change in the non-6-Fr (4-Fr/5-Fr) group was not signiﬁcant (from 2.220.56 to
2.080.61; p¼0.24). In both groups, RH-PAT of the non-catheterized arm was
unchanged. At 6 months after catheterization, RHI-PAT values had not returned to
baseline (2.590.68 before catheterization and 2.240.47 at 6 months after cathe-
terization; p¼0.138).
Conclusions: Insertion of a 6-Fr catheter sheath into the radial artery impairs vascular
endothelial function as assessed by RH-PAT. In addition, such injuries do not recover
completely within 6 months. These ﬁndings suggest that smaller sheaths (<6-Fr)
should be used to prevent severe endothelial dysfunction in the radial artery during
transradial catheterization.
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Usefulness of a systematic “Crossover wire Technique” to improve percutaneous
treatment of vascular complications in Transfemoral Transcatheter Aortic Valve
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Background: Access site difﬁculties are a major cause of complications follo-
wing TAVI procedures. Different techniques have been proposed to optimize the
femoral hemostasis, advancing an angioplasty wire from the ipsilateral or con-
tralateral femoral artery in cases of vascular complications. However, once the
complication is in place, it may be difﬁcult to cross the bleeding point with a wire.
This study sought to evaluate the usefulness of a systematic "Crossover wire
Technique" advanced from the contralateral femoral artery at the beginning of the
procedure, to manage potential vascular complications and to improve the hemostasis
during TAVI procedures.
Methods: Retrospective analysis of 159 patients undergoing TAVI with 18F intro-
ducer and percutaneous closure with Prostar device were analyzed. Patients were
divided into 2 sequential groups: group I ("without wire", n¼57, treated up to July
2010) and group II (n¼112), including patients since August 2010 that underwent the
"Crossover wire technique". Pre-procedural variables, complications (VARC-2
criteria) and treatment were compared.
Results: Results are expressed in the table. Total number of vascular complications
was similar in both groups. Prostar closure failure resulted the most frequent
complication. Life threatening bleedings (3 vs 12%, p¼0.04), major vascular
complications (7 vs 18%, p¼0.04) and mortality (6 vs 18%) were lower in group II.
Surgical repair was undertaken more frequently in group I (7 vs 1%, p¼0.06) while
a percutaneous management with covered stent implantation was preferred in group II
(21 vs 9%, p¼0.05).
Conclusions: The "Crossover wire technique" does not reduce the incidence of
vascular complications but decreases their severity and clinical impact, facili-
tating a percutaneous resolution. The team experience might have inﬂuenced in the
results.acts/POSTER/Vascular Access and Closure B91
Group
1(57)
Group
2(112) p
30-day complications in both groups (VARC-2
deﬁnitions) and mortality
Bleedings 17 (30) 21 (19) 0.19
Life threatening bleedings 7 (12) 3 (3) 0.04 (*)
Major bleedings 1 (2) 6 (5) 0.42
Minor bleedings 9 (16) 12 (11) 0.47
Total vascular complications 23 (40) 31 (28) 0.54
Major vascular complication 10 (18) 7 (6) 0.04 (*)
Minor vascular complication 9 (16) 20 (18) 0.65
Closure device failure 4 (7) 5 (4) 0.72
Balloon angioplasty for complication management 8 (14) 8 (7) 0.21
Stent implantation for complication management 5 (9) 22 (20) 0.05 (*)
Surgical repair 4 (7) 1 (1) 0.06
Global mortality 10 (18) 6 (5.4) 0.02 (*)
Vascular complication mortality 3 (5) 0 (0) 0.05 (*)
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Feasibility and Safety of Transradial Coronary Intervention Using 6.5 French
Sheathless Guiding Catheter during ST-segment Elevation Acute Coronary
Syndrome (STEACS) in Patients with Small Radial Artery: A Multi Center
Registry.
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Philippe Garot1, Fouad Hage4, Thomas Hovasse2, Thierry Lefevre2, Yves Louvard5,
Marie-Claude Morice5, Thierry Unterseeh6
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4Val-De-Grace Hospital, Paris, France, 5Institut Cardiovasculaire Paris Sud,
Générale de Santé, Massy, France, 6ICPS, Quincy, France
Background: Transradial approach during STESCA is used more frequently and is
associated with reduced rate of vascular complications and mortality. However, the
small size of the radial artery is sometimes a limitation of this technique. A sheathless
guiding catheter is available which is 2 french smaller than the sheath and has
a hydrophilic coating along its entire length. The aim of this study is to investigate the
feasibility and the safety of using this sheathless catheter during STEACS treatment in
patients with small radial arteries.
Methods: From March 2009 to May 2013 in three french hospitals, 40 patients had
a primary PCI through transradial approach using sheathless catheter after failure to
introduce 6F sheath or severe frictions with 5F angiography catheter.
Results: The 40 patients were 65.62  16.41 years old (40 to 91), 23 were women
(57.5%). Patient baseline characteristics: 10 (25%) had a history of coronary artery
disease, 18 (45%) were heavy smokers, hyperlipidaemia in 20 (50%), 15 (37.5%) had
hypertension, diabetes in 7 (17.5%) and coronary family history in 5 (12.5%) patients.
12 (30%) patients had a lesion in the LAD, 22 (55%) in the RCA and 6 (15%) in the
circumﬂex coronary artery. The average volume of product of contrast is 128.55 ml .
The total number of 49 stents were used used during these procedures (20 BMS, 29
DES) with 1.2 stents/patient. Door to Balloon average time was 35.25 minutes and the
procedural time was 47.64 minutes. Adjunctive devices used in this cohort included
thrombus-aspiration catheters in 32 patients (80%) and the technique of kissing
balloon in 7 patients (17,5%) undergoing bifurcation PCIs. One patient had an acute
intra stent thrombosis treated with thromboaspiration then angioplasty with balloon
only. Rotablator atherectomy was implemented in one patient for very calciﬁed lesion.
The technical success rate of the procedures using the sheathless catheter was 100%
without any conversion to femoral approach. There were no radial artery site
complications.
Conclusions: The use of sheathless guiding catheter safely increases the feasibility of
transradial approach for primary PCI.TCT-283
Balloon-Assisted Pseudoaneurysm Injection (BAPI) for Non-surgical Treatment
of Complex Femoral Artery Pseudoaneurysm
Thomas M. Tu1, Beth Mylor2
1Louisville Cardiology Medical Group, Louisville, Kentucky, 2Baptist Health
Louisville, Louisville, KY
Background: PSA is a complication of femoral access occurring in 0.5-1.5% of
diagnostic procedures and up to 6% after interventions. Current non-surgical strategies
for management of PSA are limited by variable success rates, physical discomfort, andB92 JACC Vol 62/18/Suppl B j October 27–Novrisk of embolization. Complex anatomy (multilobar, short and wide necks, large PSA)
is associated with more complications and decreased procedural success. Surgery is
deﬁnitive, but can result in longer length of stay, incisional pain, and risk of wound
infection. Moreover, surgery increases the risk of stent thrombosis after PCI due to
DAPT cessation and prothrombotic state.
Methods: BAPI is an endovascular technique that isolates of the PSA from the
arterial circulation in order to reduce risk of embolization and allows treatment
of more complex PSA anatomy. Via the contralateral femoral approach, the PSA
neck is identiﬁed via angiography and is occluded using balloon inﬂation. With
the PSA isolated, thrombin injection is performed using ultrasound and ﬂuo-
roscopic guidance. Once the PSA is thrombosed, the balloon is deﬂated and with-
drawn. Complete obliteration of the PSA is conﬁrmed via angiography and
ultrasound.
Results: We report the largest series of BAPI to treat femoral artery PSA
not amenable to standard thrombin injection. During 2008-2013, a total of 16
patients at our institution underwent BAPI for PSA after catheterization. All had
anatomy that made them poor candidates for ultrasound-guided thrombin injection.
11 of these patients had just had coronary stenting, one had peripheral atherectomy/
PTA, two had arrhythmia ablation, and two had diagnostic catheterization. 12 of the
patients were on dual antiplatelet therapy at the time of the PSA repair. All patients
had initial success of the procedure deﬁned by thrombosis of the PSA by the end of
the catheterization. Two of the patients required an additional procedure the
following day for recurrent PSA. Both of these cases occurred early in our expe-
rience. No patients had femoral thrombosis, distal embolization, or access site
infection.
Conclusions: BAPI is a safe and effective method to treat complex femoral artery
PSA and when uninterrupted DAPT or anticoagulation is required.
TCT-284
Impact of female gender on bleeding complications and 1-year outcomes of
transradial coronary intervention. A propensity score matched analysis: Korea
TransRadial coronary Intervention registry
Jeoung-sook Shin1, Seung-Jea Tahk1, Hyoung-Mo Yang1, Hong Seok Lim1,
Byoung-Joo Choi1, So-Yeon Choi1, Myeong- Ho Yoon1
1Ajou University School of Medicine, Suwon, Korea, Republic of
Background: Besides poor clinical outcomes, female gender has been known high
risk factor of bleeding complications. Transradial coronary Intervention (TRI) was
associated with decreased bleeding complications compare to transfemoral coronary
intervention. This study aimed to investigate the impact of gender on clinical
outcomes and bleeding complications after TRI.
Methods: Korea TRI registry is a retrospective, multicenter, observational study with
4506 patients who underwent percutaneous coronary intervention from January to
December 2009 in 12 centers. We performed a propensity score matched analyses in
1828 patients (63.2% men) who received TRI. The primary outcome was 1 year major
adverse cardiac event (MACE) including cardiac death, myocardial infarction, target
vessel revascularization and stent thrombosis. Secondary outcomes included bleeding
complications, major bleeding (composite of bleeding requiring transfusion 2 units
of packed cells or bleeding that was life-threatening) and vascular access site related
bleeding.
Results: After propensity score matching (n¼1358 total, 629 in each group), there
was no difference in baseline characteristics between two groups. The proportion of
MACE did not differ in both groups (6.1% vs. 5.7%, p¼0.943). Women had higher
incidence of bleeding complications (1.6% vs. 4.6%, p¼0.016), major bleeding (1.4%
vs. 3.8%, p¼0.022) and vascular access site related bleeding (0 vs. 0.8%) than men.
On multivariate analysis, female gender (odds ratio [OR] 3.36, 95% conﬁdence
interval [CI]; 1.31-8.62, p¼0.012), age (OR 1.20, 95% CI; 1.04-1.16, p¼0.001),
diabetes (OR 2.28, 95% CI; 1.00-5.22, p¼0.052), arterial sheath size (OR 2.82, 95%
CI; 1.28-6.23, p¼0.010) and chronic kidney disease (OR 5.29, 95% CI; 1.63-17.19,
p¼0.006) were independent predictors for bleeding complications. Female gender was
also independent predictor for major bleeding (OR 2.87, 95% CI; 1.19-6.93,
p¼0.019).
Conclusions: Regardless of the access site, female gender showed higher
incidence of bleeding complications than male gender without difference in clinical
outcomes.TCT-285
Procedural And Clinical Utility Of Transulnar Approach For Coronary
Procedures Following Failure Of Radial Route.
Mansour Sallam1, Mohammad M. Abdallah Misbah2, Adil B. Al-Riyami1
1Sultan Qaboos University Hospital, Muscat, Oman, 2Sultan Qaboos University
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Background: Background and Objectives: Radial access for coronary procedures has
gained sound recognition. However, it is not always successful. Few publications
described ulnar route as a feasible approach for coronary intervention. The aim of this
study is to assess whether transulnar approach is feasible and safe as an alternative to
the transradial approach.ember 1, 2013 j TCT Abstracts/POSTER/Vascular Access and Closure
